A federal jury ordered Medtronic to hand a competitor about $382 million after ruling the Minnesota-run medtech company violated anti-monopoly laws by selling technology to hospitals with unlawfully ...
Medtronic not only performed better than expected in its most recent quarter, but also raised its guidance. The company's innovation is paying off, and will do so again as it launches new products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results